ShockWave Medical stock saw a welcome improvement to its Relative Strength (RS) Rating on Monday, with an increase from 81 to 92.
When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength. This unique rating tracks technical performance by using a 1 (worst) to 99 (best) score that shows how a stock's price action over the last 52 weeks matches up against other publicly traded companies.
Decades of market research reveals that the market's biggest winners typically have an RS Rating of over 80 as they begin their largest runs.
Looking For Winning Stocks? Try This Simple Routine
Is ShockWave Medical Stock A Buy?
ShockWave Medical stock is not currently offering a proper buying opportunity. See if the stock goes on to build a chart pattern that could spark a new run.
While the company's top line growth fell last quarter from 271% to 194%, the bottom line grew 157%, up from 0% in the previous report. Keep an eye out for the company's next round of numbers on or around Aug. 9.
Shockwave Medical stock holds the No. 2 rank among its peers in the Medical-Systems/Equipment industry group. Haemonetics is the top-ranked stock within the group.
